SIRT5 overexpression facilitates ovarian cancer cell growth and cisplatin-resistance in an in vitro A2780 cell model, because SIRT5 suppresses cisplatin-induced DNA damage by increasing NRF2 and Haem Oxygenase 1 (HO-1) expression [56]. The gene discussed is NFE2L2; the disease is ovarian carcinoma.